We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Linezolid in the treatment of extensively drug-resistant tuberculosis.
- Authors
Zhang, L.; Pang, Y.; Yu, X.; Wang, Y.; Gao, M.; Huang, H.; Zhao, Y.
- Abstract
Purpose: To investigate the linezolid (LZD) treatment outcome and correlation between in vitro susceptibility to LZD and clinical outcome. Methods: We retrospectively reviewed records of tuberculosis (TB) patients who received treatment with linezolid between March 2012 and February 2013. Results: A total of 43 extensively drug-resistant (XDR) TB patients identified by drug susceptibility testing were enrolled in this study, including 15 (34.9 %) received LZD as part of individualized treatment regimens. Among the 43 XDR TB patients, 15 patients (34.9 %) obtained favorable clinical outcome, including 9 (60.0 %) from LZD group and 6 (21.4 %) from control group without LZD. Statistical analysis revealed that the percentage of favorable outcomes of LZD group was significantly higher than that of control group ( P = 0.011). Furthermore, we analyzed the LZD minimum inhibitory concentrations of Mycobacterium tuberculosis (MTB) isolates from patients in LZD group and identified 4 (26.7 %) resistant to LZD. All of the patients with LZD resistance harbored adverse clinical outcome, while most of the patients infected with LZD sensitive MTB harbored favorable clinical outcome (81.8 %, 9/11). Statistical analysis revealed that the percentage of favorable outcome among the patients with LZD resistance was statistically lower than that among the LZD susceptible group ( P = 0.011). Conclusion: This study demonstrates that linezolid has efficacy against XDR pulmonary TB patients, even in shorter duration of administration. The XDR TB patients infected with LZD-resistant isolates were more likely to obtain the adverse clinical outcome under the treatment of regimen containing LZD.
- Subjects
CHINA; CONFIDENCE intervals; FISHER exact test; RESEARCH methodology; MYCOBACTERIUM tuberculosis; HEALTH outcome assessment; POLYMERASE chain reaction; RESEARCH funding; TREATMENT effectiveness; RETROSPECTIVE studies; DATA analysis software; DESCRIPTIVE statistics; SEQUENCE analysis; IN vitro studies; LINEZOLID; ODDS ratio; THERAPEUTICS
- Publication
Infection, 2014, Vol 42, Issue 4, p705
- ISSN
0300-8126
- Publication type
Article
- DOI
10.1007/s15010-014-0632-2